Literature DB >> 19540282

Appearance of mosaic enterovirus 71 in the 2008 outbreak of China.

Nai-Zheng Ding1, Xing-Ming Wang, Shuang-Wu Sun, Qian Song, Shan-Ni Li, Cheng-Qiang He.   

Abstract

Enterovirus 71 (EV71) is a pathogen of hand-foot-and-mouth disease (HFMD). In the last year and this spring, HFMD caused by EV71 repeatedly broke out and has resulted in at least 50 children's death in China. It is important to know the mechanism effecting genetic diversity of the virus circulating in China in order to prevent future outbreaks in the country. Homologous recombination has been proved to play a role in evolution of the virus. In this study, we have performed a phylogenetic analysis of full-length EV71 isolated in the last year in China to detect if recombination exerts its influence on the EV71 outbreak. Among EV71 isolates from China, 5 isolates were identified as mosaic. This finding suggests that homologous recombination has played some roles in generating genetic diversity in the outbreak of EV71 in China.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19540282     DOI: 10.1016/j.virusres.2009.06.006

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  33 in total

1.  Prolonged exclusive breastfeeding, autumn birth and increased gestational age are associated with lower risk of fever in children with hand, foot, and mouth disease.

Authors:  Q Zhu; Y Li; N Li; Q Han; Z Liu; Z Li; J Qiu; G Zhang; F Li; N Tian
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-01-26       Impact factor: 3.267

2.  A comparison of the biological characteristics of EV71 C4 subtypes from different epidemic strains.

Authors:  Li-chun Wang; Song-qing Tang; Yan-mei Li; Hong-lin Zhao; Cheng-hong Dong; Ping-fang Cui; Shao-hui Ma; Yun Liao; Long-ding Liu; Qi-han Li
Journal:  Virol Sin       Date:  2010-04-09       Impact factor: 4.327

3.  Coxsackievirus A16 infection stimulates imbalances of T cells in children.

Authors:  Qingming Luo; Wanjun Peng; L I Chen
Journal:  Exp Ther Med       Date:  2015-04-03       Impact factor: 2.447

Review 4.  Virus infections and type 1 diabetes risk.

Authors:  Merja Roivainen; Karin Klingel
Journal:  Curr Diab Rep       Date:  2010-10       Impact factor: 4.810

5.  Enterovirus A71 Infection Activates Human Immune Responses and Induces Pathological Changes in Humanized Mice.

Authors:  Yanyan Ke; Wai Nam Liu; Zhisheng Her; Min Liu; Sue Yee Tan; Yong Wah Tan; Xue Ying Chan; Yong Fan; Edwin Kunxiang Huang; Huiyi Chen; Kenneth Tou En Chang; Jerry Kok Yen Chan; Justin Jang Hann Chu; Qingfeng Chen
Journal:  J Virol       Date:  2019-01-17       Impact factor: 5.103

6.  Determinants of EV71 immunogenicity and protection against lethal challenge in a mouse model.

Authors:  Junliang Chang; Jingliang Li; Wei Wei; Xin Liu; Guanchen Liu; Jiaxin Yang; Wenyan Zhang; Xiao-Fang Yu
Journal:  Immunol Res       Date:  2015-07       Impact factor: 2.829

7.  Analysis of synonymous codon usage in enterovirus 71.

Authors:  Hua Zhang; Hong-Wei Cao; Feng-Qi Li; Zi-Ye Pan; Zhi-Jun Wu; Yan-Hong Wang; Yu-Dong Cui
Journal:  Virusdisease       Date:  2014-05-21

8.  The cross-reactivity of the enterovirus 71 to human brain tissue and identification of the cross-reactivity related fragments.

Authors:  Chun Shi Jia; Jiang Ning Liu; Wan Bo Li; Chun Mei Ma; Shu Zhu Lin; Yi Hao; Xue Zhong Gao; Xiao Lin Liu; Yan Feng Xu; Lian Feng Zhang; Chuan Qin
Journal:  Virol J       Date:  2010-02-22       Impact factor: 4.099

9.  Identification of microRNAs involved in the host response to enterovirus 71 infection by a deep sequencing approach.

Authors:  Lunbiao Cui; Xiling Guo; Yuhua Qi; Xian Qi; Yiyue Ge; Zhiyang Shi; Tao Wu; Jun Shan; Yunfeng Shan; Zheng Zhu; Hua Wang
Journal:  J Biomed Biotechnol       Date:  2010-06-10

10.  The association of recombination events in the founding and emergence of subgenogroup evolutionary lineages of human enterovirus 71.

Authors:  E C McWilliam Leitch; M Cabrerizo; J Cardosa; H Harvala; O E Ivanova; S Koike; A C M Kroes; A Lukashev; D Perera; M Roivainen; P Susi; G Trallero; D J Evans; P Simmonds
Journal:  J Virol       Date:  2011-12-28       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.